The global urinary Incontinence Treatment Devices Market was valued at USD 3.15 billion in 2023 and is projected to reach USD 6.38 billion by 2032, expanding at a compound annual growth rate (CAGR) of 8.18% from 2024 to 2032. The increasing prevalence of urinary disorders, rising aging population, and growing awareness around pelvic health are among the key factors fueling market growth.

Urinary incontinence—a condition marked by involuntary urine leakage—affects millions of people worldwide, significantly impacting quality of life, especially among older adults and women. This increasing burden has prompted innovations and investments in treatment technologies, particularly non-invasive and minimally invasive urinary incontinence devices.

Market Drivers

1. Aging Population and Prevalence of Urological Disorders

One of the primary drivers of the urinary incontinence treatment devices market is the global rise in geriatric populations. Aging is closely associated with weakened bladder control and pelvic floor muscles, leading to stress, urge, or mixed incontinence. As the global elderly demographic grows, so does the patient pool requiring long-term incontinence care and intervention.

According to the WHO, the global population aged 60 years and above will double by 2050, reaching approximately 2.1 billion. This demographic trend is expected to significantly boost the demand for advanced continence care devices.

2. Increased Awareness and Acceptance of Incontinence Solutions

Urinary incontinence has historically been underdiagnosed and undertreated due to social stigma. However, public health campaigns, telehealth consultations, and educational initiatives have helped reduce the stigma and encourage patients to seek treatment. With greater awareness of treatment options, including pelvic floor therapy, electrical stimulation devices, and urethral slings, more individuals are proactively addressing the issue.

3. Technological Advancements in Incontinence Devices

The market has witnessed an influx of innovative solutions, such as wireless pelvic floor stimulation devices, implantable neurostimulators, and AI-powered wearable sensors. These technologies offer less invasive, user-friendly, and more effective options for managing incontinence.

Companies are investing heavily in R&D to develop smart continence management tools, which are integrated with mobile apps for real-time monitoring, compliance tracking, and improved patient outcomes.

Key Segments

By Product

  • Urethral Slings
    • Female Slings
    • Male Slings
  • Electrical Stimulation Devices
    • Implantable
    • Non-implantable
  • Artificial Urinary Sphincters
  • Catheters

By Incontinence Type

  • Stress Urinary Incontinence
  • Urge Urinary Incontinence
  • Mixed Incontinence
  • Overflow Incontinence

By End-user

  • Hospitals
  • Ambulatory Surgery Centers
  • Clinics
  • Home Use

 

 Key Players and Their Urinary Incontinence Treatment Devices

  • R. Bard, Inc. (Becton, Dickinson and Company) – Adjustable Continence Therapy (ACT), Urethral Slings, Catheters
  • Coloplast Group – Altis Single Incision Sling, Virtue Male Sling, Catheters
  • Promedon Group – Argus Adjustable Sling System, Remeex System
  • M.I. GmbH – ATOMS Adjustable Sling, TOA Sling System
  • Ethicon US, LLC. (Johnson & Johnson) – Gynecare TVT Sling System
  • ZSI Surgical Implants S.R.L. – ZSI 375 Artificial Urinary Sphincter
  • Medtronic plc – InterStim Sacral Neuromodulation System
  • InControl Medical LLC – Attain Pelvic Floor Exerciser, Apex M Electrical Stimulation Device
  • Hollister Incorporated – VaPro Plus Catheters, OnliReady Urinary Catheter
  • Atlantic Therapeutics Group Ltd. – INNOVO Electrical Stimulation Device
  • Braun Melsungen AG – Actreen Intermittent Catheters, Urimed Catheters
  • Teleflex Incorporated – Male Slings, Catheter Solutions (Rüsch, LMA, Arrow Brands)

 Future Outlook

The urinary incontinence treatment devices market is set to undergo significant transformation. As technology becomes more sophisticated and patient-centric, the focus will shift toward personalized treatment pathways, digital health integration, and preventive care. The rising demand for non-invasive and discreet solutions will continue to drive innovation.

Despite challenges such as device costs and reimbursement barriers in some developing regions, the long-term growth potential remains robust. Industry players who prioritize affordability, accessibility, and technological integration will be best positioned to lead in this rapidly evolving landscape.

 About US

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Jagney Dave - Vice President of Client Engagement

Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)